The estimated Net Worth of Ron Laufer is at least $13.9 millió dollars as of 30 June 2015. Ron Laufer owns over 223,439 units of Astria Therapeutics Inc stock worth over $13,942,848 and over the last 9 years Ron sold CATB stock worth over $0.
Sign up
Ron Laufer CATB stock SEC Form 4 insiders trading
Ron has made over 2 trades of the Astria Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Ron bought 223,439 units of CATB stock worth $2,681,268 on 30 June 2015.
The largest trade Ron's ever made was buying 223,439 units of Astria Therapeutics Inc stock on 30 June 2015 worth over $2,681,268. On average, Ron trades about 223,439 units every 0 days since 2015. As of 30 June 2015 Ron still owns at least 1,632,652 units of Astria Therapeutics Inc stock.
You can see the complete history of Ron Laufer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Ron Laufer's mailing address?
Ron's mailing address filed with the SEC is C/O MEDIMMUNE VENTURES, INC., ONE MEDIMMUNE WAY, GAITHERSBURG, MD, 20878.
Insiders trading at Astria Therapeutics Inc
Over the last 9 years, insiders at Astria Therapeutics Inc have traded over $0 worth of Astria Therapeutics Inc stock and bought 3,064,797 units worth $36,777,564 . The most active insiders traders include Jean George, Nicholas Galakatos és Lifesciences Ii, L.P.Clarus.... On average, Astria Therapeutics Inc executives and independent directors trade stock every 0 days with the average trade being worth of $2,617,339. The most recent stock trade was executed by Lifesciences Ii, L.P.Clarus... on 30 June 2015, trading 376,695 units of CATB stock currently worth $4,520,340.
What does Astria Therapeutics Inc's logo look like?
Complete history of Ron Laufer stock trades at Astria Therapeutics Inc
Astria Therapeutics Inc executives and stock owners
Astria Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Jill Milne,
President, Chief Executive Officer, Co-Founder, Director -
Joanne Donovan,
Chief Medical Officer -
Andrew Nichols,
Chief Scientific Officer -
Kenneth Bate,
Independent Chairman of the Board -
Michael Kishbauch,
Independent Director -
Gregg Lapointe,
Independent Director -
Burt Adelman,
Independent Director -
Hugh Cole,
Independent Director -
Joanne Beck,
Independent Director -
Andrew Komjathy,
Chief Commercial Officer -
Benjamin Harshbarger,
Senior Vice President, General Counsel -
Noah Clauser,
Chief Financial Officer -
Andrea Matthews,
IR Contact Officer -
Rick Modi,
Chief Business Officer -
Jean George,
Director -
V, Llcsv Life Sciences Fund...,
-
Ron Laufer,
Director -
Michael Jay Ross,
Director -
Michael Jirousek,
Chief Scientific Officer -
Lifesciences Ii, L.P.Clarus...,
-
Ian C. Sanderson,
Chief Financial Officer -
Ventures, Inc. Med Immune,
10% owner -
Nicholas Galakatos,
Director -
Edward K. Hibben,
Chief Business Officer -
Fred Callori,
Director -
Jonathan Violin,
Director -
Deirdre A. Cunnane,
Chief Legal Officer -
Advisors Llcperceptive Life...,